Work

Phase I study of BAY 73–4506, an inhibitor of oncogenic and angiogenic kinases, in patients with advanced refractory colorectal carcinoma (CRC)

Year: 2009

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2009.27.15_suppl.3560

Authors: D. Strumberg, M. E. Scheulen, A. Frost, M. Büchert, O. Christensen, A. Wagner, R. Heinig, U. Fasol, K. Mross

Institutions: University Medical Center Freiburg, Universitätsklinik Marien Hospital Herne

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2249145015

Cites:

Cited by: 14

Related to: 10